23
Jun

Canadian biotech Clementia Pharmaceuticals raised $60 million in mezzanine cash to help it fashion a once-failed Roche drug into a promising treatment for a rare disease.

…read more

Source: Clementia bags $60M to push a repurposed Roche drug through Phase II

    

0 No comments